Skip to main content
Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · Real-Time Price · USD
6.38
-0.14 (-2.15%)
At close: Dec 20, 2024, 4:00 PM
6.36
-0.02 (-0.31%)
After-hours: Dec 20, 2024, 5:20 PM EST

Kezar Life Sciences Revenue

In the year 2023, Kezar Life Sciences had annual revenue of $7.00M.

Revenue (ttm)
$7.00M
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
58
Market Cap
46.55M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20237.00M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fortress Biotech 81.50M
Cytosorbents 37.74M
iCAD, Inc. 18.94M
Omega Therapeutics 8.10M
Nutriband 2.02M
vTv Therapeutics 1.00M
Inovio Pharmaceuticals 203.41K
Revenue Rankings

KZR News

More News